Cost-effectiveness of bevacizumab-based therapy versus cisplatin plus pemetrexed for the first-line treatment of advanced non-squamous NSCLC in Korea and Taiwan
- Myung Ju Ahn
- , Chun Ming Tsai
- , Te Chun Hsia
- , Elaine Wright
- , John Wen Cheng Chang
- , Heung Tae Kim
- , Joo Hang Kim
- , Jin Hyoung Kang
- , Sang We Kim
- , Eun Jin Bae
- , Mijeong Kang
- , Johanna Lister
- , Stefan Walzer
- Veterans General Hospital-Taipei
- China Medical University Taichung
- Roche Korea Co. Ltd.
- Chang Gung University
- National Cancer Center Korea
- Yonsei University
- The Catholic University of Korea
- University of Ulsan
- Analytica International Inc.
Research output: Contribution to journal › Article › peer-review
22
Link opens in a new tab
Scopus
citations